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1. Introduction 
In the elongation cycle, the binding of the ternary 
complex EF-Tu . GTP . aa-tRNA to the mRNA . ribo- 
some complex is accompanied by the hydrolysis of 
GTP, a prerequisite for the release of EF-Tu from the 
ribosome (review [ 1 I). We have utilized the antibiotic 
kirromycin to analyze the role of the individual com- 
ponents of the EF-Tudependent GTPase reaction, 
since this compound allows EF-Tu to support a turn- 
over of GTPase activity which is specifically stimulated 
by aa-tRNA and ribosomes [2-61. As in the physio- 
logical system, only aminoacylated tRNA and not 
deacylated tRNA orN-acetylaminoacyl-tRNA displays 
an effect in the kirromycin-dependent activity. Kirro- 
mycin can be therefore a useful tool to study the 
involvement of the 3’-terminal end of aa-tRNA in the 
GTPase activity of EF-Tu. 
Here, we show that 3’-terminal aa-tRNA fragments, 
containing l-5 residues, can stimulate the GTPase 
activity of EF-Tu induced by kirromycin. The effect, 
which occurs already with 2’(3’)-O-L-aminoacyladen- 
osine, is increased by the presence of the other resi- 
dues, the penultimate one playing a critical role. Ribo- 
somes enhance the sensitivity of the system. 
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2. Materials and methods 
All biological components, materials and methods 
not quoted in this section were as in [2-81. Pure EF- 
Tu and NH4C1-washed ribosomes were from Esche- 
richia coli MRE 600. Kirromycin (= mocimycin, [S]) 
was obtained from Dr H. Wolf (University of Tiibingen) 
and Dr R. Beukers (Gist-Brocades, Delft). Cytosine3’- 
monophosphate was from Boehringer and puromycin 
from Sigma or Serva. The tRNAPhe (25-1000/c pure) 
and tRNA7” (25-50% pure, a gift of Dr G. Sander) 
were isolated from total tRNA (Schwarz/Mann) by 
chromatography on BD-cellulose and Sepharose 4B 
(Pharmacia) [9,10]. The various 3’-terminal fragments 
(CACCA-Phe, CCA-Phe, CA-Phe, A-Phe, CCA-Val, 
CA-Val and A-Val) were obtained from [ 14C]Phe- 
tRNAPhe (spec. act. 50 cpm/pmol) and [ 14C]Val- 
tRNA\ia’ (spec. act. 50 cpm/pmol) according to 
known methods of enzymatic digestion with RNase 
T1 (Calbiochem), RNase UZ, calf spleen phosphodi- 
esterase and pancreatic RNase (all from Boehringer) 
[ 11 ,121. They were purified by chromatography on 
DEAE-Sephadex A-25 (Pharmacia) at pH 4.5, fol- 
lowed by chromatography on SP-Sephadex C-25 
(Pharmacia) at pH 3.5. Elutions were carried out 
with a gradient of ammonium acetate. For CA-Phe 
and CA-V.al an additional electrophoretic step on 
Whatmann 3 MM paper at pH 3.5 and 50 V/cm (Gilson 
Electrophorator) was employed. Purity of the frag- 
ments, calculated spectrophotometrically and by spe- 
cificactivity,was90-lOO%.The fragmentswere>95% 
aminoacylated. After lyophilisation, the fragments 
were dissolved in 2 mM acetic acid and kept at -70°C. 
Particular care was taken to avoid the presence of 
monovalent cations in the final solution, since they 
greatly influence the EF-Tu . kirromycin GTPase 
activity [7]. 
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To increase the stimulatory effect of aa-tRNA, in 
the absence of ribosomes we have worked at 25 mM 
NH4C1 while the MgCl, concentration, which is not 
critical, was 10 mM. Stimulation by Phe-tRNA was 
-7-fold. Since in these ionic conditions ribosomes 
enhance the GTPase activity of EF-Tu . kirromycin in 
the absence of aa-tRNA considerably [7], in their 
presence we have modified the ionic concentrations 
(5 mM NH4C1 and 30 mM M&l*) to obtain a stronger 
stimulation by aa-tRNA (9-12-fold with Phe- 
tRNAPhe) thanks to the lower background of GTPase 
activity. Under all conditions tested the GTP concen- 
tration was saturating and the reaction kinetics linear. 
Most assays were carried out in 10 ~1 final vol., the 
results being comparable with those obtained in 15 and 
75 1.11. The reaction was started with [y-32P]GTP (spec. 
act. 1500-4000 cpm/pmol). The non-hydrolyzed 
[T-~‘P]GTP was sequestered by addition of activated 
charcoal in 1 M HCl [ 131 and the mixture was centri- 
fuged for 15 min at 5000 rev./min. An aliquot of the 
supernatant was added to Aquasol 2 (New England 
Nuclear) and the radioactivity of 32Pi counted in an 
Intertechnique SL 4000 liquid scintillation spectrom- 
eter. 
3. Results 
To obtain some indications of the role of the amino 
acid residuds in the interaction with EF-Tu, we have 
done our experiments with fragments derived from 
two different aa-tRNAs. 
Fig.1 illustrates the effect of increasing concentra- 
tions of Phe-tRNAPhe (panel A) and Val-tRNAyd 
(panel B) and their 3’-terminal fragments on the rate 
of the EF-Tu-dependent GTP hydrolysis induced by 
kirromycin in the absence of ribosomes. Stimulation 
of the GTPase activity by CACCA-Phe, the longest 
aminoacyloligonucleotide used, was stronger than 
with CCA-Phe and A-Phe, the latter fragment being 
by far the least active. In this system CA-Phe was not 
tested. A similar pattern was observed with the 
3’-terminal fragments derived from Val-tRNAFl:CCA- 
Val and CA-Val were both as active as CCA-Phe while 
the effect of A-Val was as little as that of A-Phe. With 
both intact aa-tRNAs, stimulation was,however,much 
stronger than with the derived fragments. 
Fig.2 illustrates the same series of experiments in 
the presence of ribosomes. Also in this system the 
intact aa-tRNA was the most effective. Panel A shows 
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1:ig.l. The rate of GTP hydrolysis catalyzed by Et:-Tu in the 
presence of kirromycin as a function of the concentration of 
Phe-tRNAPhe (A), V&RNA?’ (B) and their 3’.terminal 
fragments. The reaction mixture contained in 10 ~1 final vol.: 
50 mM imidazolium acetate (pH 7 .O); 25 mM NH,Cl; 10 mM 
M&l,; 30 pmol [y-‘2P]CTP (spec. act. 3500 cpm/pmol); 
Phe-tRNAPhe (A) or Val-tRNA?al (B) and the respective 
3’.terminal fragments as indicated; 50 PM kirromycin;4 pmol 
BF-Tu. After 15 min incubation at 30°C the reaction was 
stopped with 50 ~1 0.6 M HCIO, and the .‘ZPi liberated was 
measured as in section 2. (A) Phc-tRNAPhe (0); CACCA-Phe 
(A); CCA-Phe (A); A-Phe (a). (B) Val-tRNAp’ (0); CCA-Val 
(A); CA-Val (0); A-Val (=). 
Fig.2. The rate of (;TP hydrolysis catalyzed by EF-Tu in the 
presence of kirromycin and ribosomes as a function of the 
concentration of Phe-tRNAPhe (A), Val-tRNApl (B) and 
their 3’-terminal fragments. The reaction mixture contained 
in 10 ~1 final vol.: 30 mM imidazolium acetate (pH 7.0); 
5 mM NH&l, 30 mM MgCI,, 100 pmol [y-“P]GTP 
I 1500 cpm/pmol), Phe-tRNAPhe (A) or Val-tRNAp 
spec.act. 
(B) and 
the respective fragments as indicated; 50 MM kirromycin; 
4 pmol EF-Tu; 4 pm01 70 S ribosomes. After 15 min incuba- 
tion at 3O”C, the reaction was stopped with 50 ~10.6 M 
HClO, and the “Pi liberated was measured as in section 2. 
(A) Phe-tRNAPh” (G); CACCAPhe (‘4); CCAPhe (A); CA-Phe 
(0); A-Phe (=). (B) Val-tRNAp’ (0); CCA-Val (A); CA-Vat 
(n); A-Val (=). (A,B) EF-Tu + kirromycin and ribosomes 
without additions (--). 
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that CCA-Phe enhances the rate of GTP hydrolysis as 
well as CACCAPhe. CA-Phe was 50% as effective, 
while APhe was again the least effective. Stimulation 
by CCA-Val reached almost that obtained with 
Val-tRNAyat; CA-Val was somewhat less active than 
CCA-Val, while stimulation by A-Val was very small, 
being almost that of A-Phe. 
In both systems, saturating concentrations of 
Phe-tRNAP1re induced a 50% stronger stimulation than 
did Val-tRNAya’. The difference in the stimulation by 
the intact molecules was not conserved in the magni- 
tude of the effect for their derived fragments. 
Deacylated 3’-terminal fragments were inactive (not 
shown). 
The effects described in fig.1 and 2 were evaluated 
by double reciprocal plots of the increment in GTPase 
activity vs the concentrations of 3’-terminal fragments 
or aa-tRNA. Table 1 reported the values obtained for 
the concentrations required for half-maximum stimu- 
lation of the rate of the GTP hydrolysis. These values 
can be considered to represent the apparent dissocia- 
tion constant (Kd) of the aminoacylated 3’-terminal 
fragments or aa-tRNA from the EF-Tu . kirromycin 
complex. The required concentration for aa-tRNA is 
lower than for aminoacylddenosine by 2 orders of 
magnitude, while the difference is reduced to 1 order 
of magnitude only for the longer fragments. This 
already occurs with CA-Phe and CA-Val, indicating 
that the penultimate residue mostly contributes to 
the effect of the aminoacyl-oligonucleotides on the 
EF-Tu center for GTP hydrolysis. Ribosomes enhance 
Table 1 
Concentration of Phe-tRNAPhe, Val-tRNAVa’ and their 
3’-terminal fragments inducing half-maximum stimulation 
of the EF-Tu GTPase activity in the presence of kirromycin 
__.__ 
-Ribosomes +Ribosomcs 
GM) (PM) 
_ - 
Phe-tRNAPhe 1.2 0.2 ’ 
CACCA-Phe 80 6 
CCA-Phe 100 6 
CA-Phe n.d. 10 
A-Phe 500 15 
Val-tRNAVal I .5 0.15 
CCA-Val 100 12 
CA-Val 100 17 
A-Val 1000 140 
_ 
The values represent the average of different experiments; 
n.d., not determined 
the sensitivity of the system from 6-l 5-times, without 
greatly changing the general picture. The difference in 
stimulation between A-Phe or A-Val and the longer 
fragments was retained also at infinite concentrations 
(not shown). 
The addition of cytosine 3’-monophosphate up to 
1 mM did not increase the weak effect of A-Phe or 
A-Val either in the absence or in the presence of ribo- 
somes (not shown). 
We also investigated whether puromycin, an anal- 
ogue of aminoacyladenosine, could stimulate the 
GTPase activity of EF-Tu in the presence of kirromy- 
tin. Neither in the presence, not in the absence of 
ribosomes were we able to observe any effect by using 
puromycin over 10 PM-S mM (not shown). 
4. Discussion 
The use of kirromycin to activate the EF-Tu center 
for GTP hydrolysis facilitates the study of the regula- 
tion of this activity by aa-tRNA, ribosomes and 
cations [S]. Moreover, it permits to quantify precisely 
the effects, since in the presence of kirromycin the 
rate-limiting step of the turnover of the GTPase activ- 
ity of EF-Tu is always GTP breakdown [6]. 
Our results show that 3’-terminal fragments of 
aa-tRNA are able to stimulate the catalytic activity of 
EF-Tu independently of the other domains of the 
aa-tRNA molecule. Though 2’(3’)a-L-aminoacyl- 
adenosine alone can stimulate the EF-Tu GTPase 
activity, the presence of the penultimate residue 
appears to be critical for a productive interaction with 
EF-Tu. The observation that addition of cytosine 
3’-monophosphate does not influence the effect of 
A-Phe or A-Val suggests that the cytidylic acid residue 
does not act directly on EF-Tu but affects the config- 
uration of the aminoacyl-adenosine moiety [ 141. The 
presence of other residues besides the penultimate 
residue appears to be less important. 
Ribosomes, which strongly stimulate the catalytic 
activity of EF-Tu . kirromycin, appear to favor the 
activity of the 3’-terminal fragments even more than 
that of aa-tRNA. This observation as well as the size 
of the observed effects point to a prominent role of 
the 3’-terminal end in the interaction between aa-tRNA 
and EF-Tu. That the intact molecule is still more 
active than the derived fragments may depend either 
on additional interactions between other domains of 
the tnolecule and EF-Tu, or on a more specific posi- 
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tioning of the 3’-terminal end due to the intact accep- 
tor stem. 
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